These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 10613661
21. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA, Dempfle CE, Matsuda M, Heene DL. Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [Abstract] [Full Text] [Related]
22. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test. Hafter R, Schröck R, von Hugo R, Graeff H. Scand J Clin Lab Invest Suppl; 1985 Sep; 178():137-44. PubMed ID: 3867114 [Abstract] [Full Text] [Related]
23. A soluble fibrin standard: comparable dose-response with immunologic and functional assays. McCarron BI, Marder VJ, Kanouse JJ, Francis CW. Thromb Haemost; 1999 Jul; 82(1):145-8. PubMed ID: 10456469 [Abstract] [Full Text] [Related]
25. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Wiman B, Rånby M. Thromb Haemost; 1986 Apr 30; 55(2):189-93. PubMed ID: 3087001 [Abstract] [Full Text] [Related]
26. Degradation of cross-linked fibrin by human leukocyte proteases. Francis CW, Marder VJ. J Lab Clin Med; 1986 Apr 30; 107(4):342-52. PubMed ID: 3514776 [Abstract] [Full Text] [Related]
27. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot]. Okumura N, Kagiya H, Kumagai T, Kameko M, Tozuka M, Saito H, Katsuyama T, Kanai M. Rinsho Byori; 1990 Feb 30; 38(2):201-7. PubMed ID: 2329722 [Abstract] [Full Text] [Related]
28. Evaluation of the factors contributing to fibrin-dependent plasminogen activation. Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W. Thromb Haemost; 1998 Apr 30; 79(4):796-801. PubMed ID: 9569195 [Abstract] [Full Text] [Related]
29. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. Cugno M, Mari D, Meroni PL, Gronda E, Vicari F, Frigerio M, Coppola R, Bottasso B, Borghi MO, Gregorini L. Br J Haematol; 2004 Jul 30; 126(1):85-92. PubMed ID: 15198737 [Abstract] [Full Text] [Related]
34. Comparison of the diagnostic performance of three soluble fibrin monomer tests and a D-dimer assay in patients with clinically suspected deep vein thrombosis of the lower limbs. Elias A, Cazanave G, Nguyen F, Elias M, Bongard V, Cambus JP. Haematologica; 2004 Apr 30; 89(4):499-501. PubMed ID: 15075088 [Abstract] [Full Text] [Related]
35. Unreliability of current serum fibrin degradation product (FDP) assays. Gaffney PJ, Perry MJ. Thromb Haemost; 1985 Jun 24; 53(3):301-2. PubMed ID: 3901388 [Abstract] [Full Text] [Related]
36. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma. Carroll RC, Lockhart MS, Taylor FB. J Lab Clin Med; 1984 May 24; 103(5):695-703. PubMed ID: 6232329 [Abstract] [Full Text] [Related]
37. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis]. Graeff H, Klaubert W, Klaubert E, Gollwitzer R, von Hugo R, Hafter R. Geburtshilfe Frauenheilkd; 1983 Jun 24; 43 Suppl 1():42-6. PubMed ID: 6555132 [Abstract] [Full Text] [Related]